These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 23089106)

  • 1. Acylcarnitine profile in thyroid disease.
    Wong S; Hannah-Shmouni F; Sinclair G; Sirrs S; Dahl M; Mattman A
    Clin Biochem; 2013 Jan; 46(1-2):180-3. PubMed ID: 23089106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum leptin and ghrelin levels in premenopausal women with stable body mass index during treatment of thyroid dysfunction.
    Braclik M; Marcisz C; Giebel S; Orzeł A
    Thyroid; 2008 May; 18(5):545-50. PubMed ID: 18466078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
    Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum bone Gla protein (BGP) during treatment of hyperthyroidism and hypothyroidism. A longitudinal study.
    Faber J; Perrild H; Johansen JS
    Horm Metab Res; 1991 Mar; 23(3):135-8. PubMed ID: 1864560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Beta-carotene, vitamin A and carrier proteins in thyroid diseases].
    Aktuna D; Buchinger W; Langsteger W; Meister E; Sternad H; Lorenz O; Eber O
    Acta Med Austriaca; 1993; 20(1-2):17-20. PubMed ID: 8475673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum amino-terminal propeptide of type III procollagen in patients with hyperthyroidism or hypothyroidism during therapy.
    Kucharz EJ; Jurecka-Tuleja B; Jonderko G; Marcisz C
    Thyroid; 1994; 4(2):191-4. PubMed ID: 7920002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Homologous radioimmunoanalysis of serum L-thyroxine and triiodo-L-thyronine in rats with hypo- and hyperthyroidism].
    Fernández-Pastor VJ; Morell M
    Rev Esp Fisiol; 1987 Jun; 43(2):157-62. PubMed ID: 3659541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of direct equilibrium dialysis and analogue-type free thyroid hormone assays, and an immunoradiometric TSH method in patients with thyroid dysfunction.
    Liewendahl K; Mähönen H; Tikanoja S; Helenius T; Turula M; Välimäki M
    Scand J Clin Lab Invest; 1987 Sep; 47(5):421-8. PubMed ID: 3659820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle carnitine in hypo- and hyperthyroidism.
    Sinclair C; Gilchrist JM; Hennessey JV; Kandula M
    Muscle Nerve; 2005 Sep; 32(3):357-9. PubMed ID: 15803480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parameters of serum binding of thyroxine in hypo-, hyper- and euthyroidism and their application to the control of therapy.
    Gordon A; Kleinerman H; Ehrenfeld M; Ehrenfeld E
    Isr J Med Sci; 1971 Sep; 7(9):1029-34. PubMed ID: 5004887
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of procollagen III peptide as a marker of tissue hyperthyroidism in long-term treated women with TSH suppressive doses of thyroxine.
    Zulewski H; Siggelkow H; Walden C; Becker W; Hüfner M
    Exp Clin Endocrinol Diabetes; 1999; 107(3):190-4. PubMed ID: 10376444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone/insulin-like growth factor axis in patients with subclinical thyroid dysfunction.
    Akin F; Yaylali GF; Turgut S; Kaptanoglu B
    Growth Horm IGF Res; 2009 Jun; 19(3):252-5. PubMed ID: 19111490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum triiodothyronin during treatment of hyper- and hypothyroidism].
    Rogowski P; Kirkegaard C; Lumholtz B; Friis T; Sierbaek-Nielsen K
    Ugeskr Laeger; 1975 Aug; 137(34):1951-4. PubMed ID: 52226
    [No Abstract]   [Full Text] [Related]  

  • 14. [New strategy for thyroid function testing].
    Toldy E; Löcsei Z; Héber S; Gundy K; Varga L; Kovács LG
    Orv Hetil; 1993 Jul; 134(29):1571-6. PubMed ID: 8101646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of thyroid dysfunction on N-terminal pro-B-type natriuretic peptide concentrations.
    Manuchehri AM; Jayagopal V; Kilpatrick ES; Atkin SL
    Ann Clin Biochem; 2006 May; 43(Pt 3):184-8. PubMed ID: 16704752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary excretion of carnitine in patients with hyperthyroidism and hypothyroidism: augmentation by thyroid hormone.
    Maebashi M; Kawamura N; Sato M; Imamura A; Yoshinaga K
    Metabolism; 1977 Apr; 26(4):351-6. PubMed ID: 846404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma cyclic AMP response to glucagon as an index of tissue responsiveness to thyroid hormone.
    Paisey R; Elkeles RS; Hambley J; Belchetz PE
    Diabete Metab; 1978 Dec; 4(4):267-70. PubMed ID: 215472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of thyrotropin, prolactin, growth hormone, triiodothyronine and thyroxine after oral administration of thyrotropin releasing hormone in hypothyroid and hyperthyroid patients.
    Nedvídková J; Felt V
    Endokrinologie; 1976; 68(2):175-82. PubMed ID: 827434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of tissue response to thyroid hormones in patients with hyperthyroidism or hypothyroidism.
    Kucharz EJ; Marcisz C; Jonderko G; Jurecka-Tuleja B; Gołab T; Gina AR
    Rom J Intern Med; 1997; 35(1-4):71-5. PubMed ID: 9562655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimisation of thyroid hormone replacement using an automated thyroid register.
    Cuthbertson DJ; Flynn R; Jung RT; Leese GP
    Int J Clin Pract; 2006 Jun; 60(6):660-4. PubMed ID: 16805748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.